Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer.

Transl Lung Cancer Res · 2021 · PMC8264341 · PMID 34295655

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

difference was apparentP=0.053so close (0.05 < p ≤ 0.1)

No corresponding significant difference was apparent for CRT and histone H3 levels [1.00 vs. 6.52 (P=0.053) and 1.00 vs. 1.26 (P=0.60), respectively].

also in 830 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.